Laryngopharyngeal motor dysfunction and obstructive sleep apnea in Parkinson’s disease

  • Christianne Martins Corrêa Silva BahiaEmail author
  • João Santos Pereira
  • Agnaldo José Lopes
Sleep Breathing Physiology and Disorders • Original Article



Obstructive sleep apnea (OSA) is a common sleep disorder in Parkinson’s disease (PD), but the relationship between these two conditions remains uncertain. Upper airway (UA) dysfunction in PD is well documented in some patients and is believed to be a reflex of the motor involvement of laryngopharyngeal muscles. The aim of this study is to determine whether UA dysfunction and laryngopharyngeal motor dysfunction (LMD) are involved in the obstructive phenomenon of OSA in PD.


Forty-eight PD patients underwent polysomnography for OSA diagnosis, functional evaluation of the UA by spirometry and a clinical protocol for analysis of laryngopharyngeal muscles and physical examination.


Thirty-one participants (64.6%) fulfilled the criteria for OSA according to the International Classification of Sleep Disorders- third edition (at least respiratory disturbance index of five or higher per hour of sleep plus specific symptoms). UA obstruction was observed in 25% of participants and LMD in 60.4%. Among the clinical indicators of LMD, hypophonia was the most common (58.3%). Participants with LMD had a threefold greater chance of presenting with OSA than those without LMD did (OR = 3.49; 95% CI, 1.01–12.1; p = 0.044). Individuals with LMD had more UA dysfunction (37.9 vs 10.5%, p = 0.037), higher scores on UPDRS III (20 vs 15, p = 0.0005) and the Hoehn-Yahr scale (2.5 vs 2.0, p = 0.008), and higher frequencies of postural changes (51.7 vs 21.1%, p = 0.033) and motor phenomena (65.5 vs 31.6%, p = 0.021). Obesity, snoring, neck circumference, and the Mallampati score did not correlate with OSA in PD.


LMD should be considered a factor that is involved in the obstructive phenomenon of UA in patients with OSA and PD.


Parkinson’s disease Laryngopharyngeal motor dysfunction Upper airway Obstructive sleep apnea Spirometry Mallampati score 


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflicts of interest.

Research involving human participants and/or animals

All procedures performed in the studies involving human participants were in accordance with the ethical standards of the Rio de Janeiro State University Research Committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Ethical approval

The study was approved by the institutional research ethics committee under number 500184.


  1. 1.
    Halliday G, Lees A, Stern M (2011) Milestones in Parkinson’s disease-clinical and pathologic features. Mov Disord 26:1015–1021. CrossRefPubMedGoogle Scholar
  2. 2.
    Cochen De Cock V, Vidailhet M, Arnulf I (2008) Sleep disturbances in patients with parkinsonism. Nat Clin Pract Neurol 4:254–266. CrossRefGoogle Scholar
  3. 3.
    Iranzo A, Tolosa E, Gelpi E, Molinuevo JL, Valldeoriola F, Serradell M, Sanchez-Valle R, Vilaseca I, Lomeña F, Vilas D, Lladó A, Gaig C, Santamaria J (2013) Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol 12:443–453. CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    De Lau LML, Breteler MMB (2006) Epidemiology of Parkinson’s disease. Lancet Neurol 5:525–535. CrossRefPubMedGoogle Scholar
  5. 5.
    Tufik S, Santos-Silva R, Taddei JA, Bittencourt LR (2010) Obstructive sleep apnea syndrome in the Sao Paulo Epidemiologic Sleep Study. Sleep Med 11:441–446. CrossRefPubMedGoogle Scholar
  6. 6.
    da Silva-Júnior FP, do Prado GF, Barbosa ER, Tufik S, Togeiro SM (2014) Sleep disordered breathing in Parkinson’s disease: a critical appraisal. Sleep Med Rev 18:173–178. CrossRefPubMedGoogle Scholar
  7. 7.
    Schwartz AR, Patil SP, Laffan AM, Polotsky V, Schneider H, Smith PL (2008) Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches. Proc Am Thorac Soc 5:185–192. CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Vincken WG, Gauthier SG, Dollfuss RE, Hanson RE, Darauay CM, Cosio MG (1984) Involvement of upper-airway muscles in extrapyramidal disorders. A cause of airflow limitation. N Engl J Med 311:438–442. CrossRefPubMedGoogle Scholar
  9. 9.
    Sabaté M, González I, Ruperez F, Rodríguez M (1996) Obstructive and restrictive pulmonary dysfunctions in Parkinson’s disease. J Neurol Sci 138:114–119. CrossRefPubMedGoogle Scholar
  10. 10.
    Shill H, Stacy M (2002) Respiratory complications of Parkinson’s disease. Semin Respir Crit Care Med 23:261–265. CrossRefPubMedGoogle Scholar
  11. 11.
    Herer B, Arnulf I, Housset B (2001) Effects of levodopa on pulmonary function in Parkinson’s disease. Chest 119:387–393. CrossRefPubMedGoogle Scholar
  12. 12.
    Sawczuk A, Mosier KM (2001) Neural control of tongue movement with respect to respiration and swallowing. Crit Rev Oral Biol Med 12:18–37. CrossRefPubMedGoogle Scholar
  13. 13.
    Mu L, Sobotka S, Chen J, Su H, Sanders I, Adler CH, Shill HA, Caviness JN, Samanta JE, Beach TG, Arizona Parkinson’s Disease Consortium (2013) Alpha-synuclein pathology and axonal degeneration of the peripheral motor nerves innervating pharyngeal muscles in Parkinson disease. J Neuropathol Exp Neurol 72:119–129. CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Baker KK, Ramig LO, Luschei ES, Smith ME (1998) Thyroarytenoid muscle activity associated with hypophonia in Parkinson disease and aging. Neurology 51:1592–1598. CrossRefPubMedGoogle Scholar
  15. 15.
    Cochen De Cock V, Abouda M, Leu S, Oudiette D, Roze E, Vidailhet M, Similowski T, Arnulf I (2010) Is obstructive sleep apnea a problem in Parkinson’s disease? Sleep Med 11:247–252. CrossRefPubMedGoogle Scholar
  16. 16.
    Maria B, Sophia S, Michalis M, Charalampos L, Andreas P, John ME, Nikolaos SM (2003) Sleep breathing disorders in patients with idiopathic Parkinson’s disease. Respir Med 97:1151–1157. CrossRefPubMedGoogle Scholar
  17. 17.
    Neikrug AB, Maglione JE, Liu L, Natarajan L, Avanzino JA, Corey-Bloom J, Palmer BW, Loredo JS, Ancoli-Israel S (2013) Effects of sleep disorders on the non-motor symptoms of Parkinson disease. J Clin Sleep Med 9:1119–1129. CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Trotti LM, Bliwise DL (2010) No increased risk of obstructive sleep apnea in Parkinson’s disease. Mov Disord 25:2246–2249. CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184. CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Brazilian Institute of Geography and Statistics (2011). Ethno-racial characteristics of the population – a study of the 2008 classification categories of color or race. Resource Accessed 20 May 2018
  21. 21.
    Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25:2649–2653. CrossRefPubMedGoogle Scholar
  22. 22.
    Bertolazi AN, Fagondes SC, Hoff LS, Pedro VD, Menna Barreto SSM, Johns MW (2009) Portuguese-language version of the Epworth sleepiness scale: validation for use in Brazil. J Bras Pneumol 35:877–883. CrossRefPubMedGoogle Scholar
  23. 23.
    Berry RB, Brooks R, Gramaldo CE, et al For the American Academy of Sleep Medicine (2017) The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. Version 2.4 American Academy of Sleep Medicine, Darien, IllinoisGoogle Scholar
  24. 24.
    American Academy of Sleep Medicine (2014) International classification of sleep disorders, 3rd edn. American Academy of Sleep Medicine, Darien, IllinoisGoogle Scholar
  25. 25.
    Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, ATS/ERS Task Force (2005) Standardisation of spirometry. Eur Respir J 26:319–338. CrossRefPubMedGoogle Scholar
  26. 26.
    Pereira CAC, Sato T, Rodrigues SC (2007) New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol 33:397–406. CrossRefPubMedGoogle Scholar
  27. 27.
    Valko PO, Hauser S, Sommerauer M, Werth E, Baumann CR (2014) Observations on sleep-disordered breathing in idiopathic Parkinson’s disease. PLoS One 9:e100828. CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Wang Y, Shao WB, Gao L, Lu J, Gu H, Sun LH (2014) Abnormal pulmonary function and respiratory muscle strength findings in Chinese patients with Parkinson’s disease and multiple system atrophy: comparison with normal elderly. PLoS One 9:e116123CrossRefGoogle Scholar
  29. 29.
    Modrykamien AM, Gudavalli R, McCarthy K, Liu X, Stoller JK (2009) Detection of upper airway obstruction with spirometry results and the flow-volume loop: a comparison of quantitative and visual inspection criteria. Respir Care 54:474–479PubMedGoogle Scholar
  30. 30.
    Hoffstein V, Oliver Z (2003) Pulmonary function and sleep apnea. Sleep Breath 7:159–165. CrossRefPubMedGoogle Scholar
  31. 31.
    Yoshida T, Kono I, Yoshikawa K, Hashimoto H, Harada H, Nakagawa M (2003) Improvement of sleep hypopnea by antiparkinsonian drugs in a patient with Parkinson’s disease: a polysomnographic study. Intern Med 42:1135–1138. CrossRefPubMedGoogle Scholar
  32. 32.
    Saletu M, Anderer P, Saletu B, Hauer C, Mandl M, Oberndorfer S, Zoghlami A, Saletu-Zyhlarz G (2000) Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 2. Findings on periodic leg movements, arousals and respiratory variables. Neuropsychobiology 41:190–199. CrossRefPubMedGoogle Scholar
  33. 33.
    Zamarron C, García Paz VC, Riveiro A (2008) Obstructive sleep apnea syndrome is a systemic disease. Current evidence. Eur J Intern Med 19:390–398. CrossRefPubMedGoogle Scholar
  34. 34.
    Chen JC, Tsai TY, Li CY, Hwang JH (2015) Obstructive sleep apnea and risk of Parkinson’s disease: a population-based cohort study. J Sleep Res 24:432–437. CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  1. 1.Movement Disorder Sector, Neurology UnitPedro Ernesto University Hospital, State University of Rio de JaneiroRio de JaneiroBrazil
  2. 2.Rehabilitation Sciences Post-Graduation ProgramAugusto Motta University CenterRio de JaneiroBrazil

Personalised recommendations